Meeting paper SGS paper| Volume 213, ISSUE 5, P718.e1-718.e7, November 2015

Download started.


Effects of dexamethasone on quality of recovery following vaginal surgery: a randomized trial


      Dexamethasone is a corticosteroid with minimal side effects that may improve quality of recovery. We sought to evaluate standard use of this medication prior to vaginal reconstructive surgery.

      Study Design

      This was a double-blind, randomized, placebo-controlled trial of women undergoing vaginal reconstructive surgery for pelvic organ prolapse. Patients scheduled for an intraperitoneal vaginal vault suspension, with general anesthesia and an overnight stay, were enrolled. The intervention arm received dexamethasone 60 minutes prior to surgery, and controls received placebo. Postoperative pain medications, antiemetics, and voiding trials were standardized. Our primary outcome was the difference in Quality of Recovery (QoR-40) scores on postoperative day 1. Secondary measures included Postoperative Nausea and Vomiting Intensity scores, and visual analog scales for nausea/vomiting, and pain. Our power calculation demonstrated 31 subjects in each group would be necessary to document difference in QoR-40 scores; to allow for attrition, a goal of 74 subjects was set.


      Seventy-four women were enrolled and randomized. Two withdrew, 9 were excluded, and 63 were analyzed (36 placebo, 27 dexamethasone). The mean age was 63 years. No significant differences were noted among demographics other than American Society for Anesthesiologists class; there were greater numbers of dexamethasone subjects that were class 3 (5 vs 11; P = .030). Postoperatively, more patients in the placebo group required promethazine as a rescue antiemetic for control of their nausea/vomiting (11 vs 2; P = .029). Placebo subjects also failed their voiding trials more frequently, which remained following a logistic regression controlling for suburethral sling (30 vs 15; P = .037). Regarding the QoR-40 following surgery, the emotional state domain declined less in dexamethasone patients (–14.3, interquartile range [IQR], 16.8 vs –4.6, IQR, 20.1; P = .042), indicating better symptoms. Whereas pain scales were similar, the visual analog scales for nausea/vomiting was lower in dexamethasone subjects (0.7; IQR, 4.1 vs 0.4; IQR, 1.4; P = .042). Postoperative Nausea and Vomiting Intensity scores were not significantly different; nevertheless, twice as many placebo subjects had severe range symptoms (4 vs 2; P = .47). No adverse effects from the dexamethasone were noted.


      Use of dexamethasone prior to vaginal reconstructive surgery was associated with less nausea/vomiting and need for antiemetics as well as greater success with voiding trials. Furthermore, quality of recovery was enhanced, suggesting use of dexamethasone should be considered for these patients.

      Key words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to American Journal of Obstetrics & Gynecology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Wu C.L.
        • Richman J.M.
        Postoperative pain and quality of recovery.
        Curr Opin Anaesthesiol. 2004; 17: 455-460
        • Myles P.S.
        • Weitkamp B.
        • Jones K.
        • et al.
        Validity and reliability of a postoperative quality of recovery score: the QoR-40.
        Br J Anaesth. 2000; 84: 11-15
        • Myles P.S.
        • Reeves M.D.
        • Anderson H.
        • et al.
        Measurement of quality of recovery in 5672 patients after anaesthesia and surgery.
        Anaesth Intens Care. 2000; 28: 276-280
        • Myles P.S.
        • Williams D.L.
        • Hendrata M.
        • et al.
        Patient satisfaction after anaesthesia and surgery: results of a prospective survey of 10,811 patients.
        Br J Anaesth. 2000; 84: 6-10
        • Jones R.
        • Daunt M.
        Should anaesthetists routinely give dexamethasone as a perioperative antiemetic?.
        Br J Hosp Med (Lond). 2014; 75: 118
        • Ahsan K.
        • Abbas N.
        • Naqvi S.M.
        • et al.
        Comparison of efficacy of ondansetron and dexamethasone combination and ondansetron alone in preventing postoperative nausea and vomiting after laparoscopic cholecystectomy.
        JPMA J Pak Med Assoc. 2014; 64: 242-246
        • Rapoport B.L.
        Efficacy of a triple antiemetic regimen with aprepitant for the prevention of chemotherapy-induced nausea and vomiting: effects of gender, age, and region.
        Curr Med Res Opin. 2014; 30: 1875-1881
        • Cardoso M.M.
        • Leite A.O.
        • Santos E.A.
        • et al.
        Effect of dexamethasone on prevention of postoperative nausea, vomiting and pain after caesarean section: a randomised, placebo-controlled, double-blind trial.
        Eur J Anaesthesiol. 2013; 30: 102-105
        • Tobi K.U.
        • Imarengiaye C.O.
        • Amadasun F.E.
        The effects of dexamethasone and metoclopramide on early and late postoperative nausea and vomiting in women undergoing myomectomy under spinal anaesthesia.
        Niger J Clin Pract. 2014; 17: 449-455
        • De Oliveira Jr., G.S.
        • Ahmad S.
        • Fitzgerald P.C.
        • et al.
        Dose ranging study on the effect of preoperative dexamethasone on postoperative quality of recovery and opioid consumption after ambulatory gynaecological surgery.
        Br J Anaesth. 2011; 107: 362-371
        • Si X.Y.
        • Wu L.P.
        • Li X.D.
        • et al.
        Dexamethasone combined with other antiemetics for prophylaxis after laparoscopic cholecystectomy.
        Asian J Surg. 2015; 38: 21-27
        • Jokela R.M.
        • Ahonen J.V.
        • Tallgren M.K.
        • et al.
        The effective analgesic dose of dexamethasone after laparoscopic hysterectomy.
        Anesth Analg. 2009; 109: 607-615
        • Collins S.A.
        • Joshi G.
        • Quiroz L.H.
        • et al.
        Pain management strategies for urogynecologic surgery: a review.
        Female Pelvic Med Reconstr Surg. 2014; 20: 310-315
        • Bump R.C.
        • Mattiasson A.
        • Bo K.
        • et al.
        The standardization of terminology of female pelvic organ prolapse and pelvic floor dysfunction.
        Am J Obstet Gynecol. 1996; 175: 10-17
        • Baggish M.S.
        • Karram M.M.
        Atlas of pelvic anatomy and gynecologic surgery.
        Elsevier Saunders, St Louis, MO2011
        • Kindler C.H.
        • Harms C.
        • Amsler F.
        • et al.
        The visual analog scale allows effective measurement of preoperative anxiety and detection of patients' anesthetic concerns.
        Anesth Analg. 2000; 90: 706-712
        • Gallagher E.J.
        • Bijur P.E.
        • Latimer C.
        • et al.
        Reliability and validity of a visual analog scale for acute abdominal pain in the ED.
        Am J Emerg Med. 2002; 20: 287-290
        • Myles P.S.
        • Wengritzky R.
        Simplified postoperative nausea and vomiting impact scale for audit and post-discharge review.
        Br J Anaesth. 2012; 108: 423-429
        • Wengritzky R.
        • Mettho T.
        • Myles P.S.
        • et al.
        Development and validation of a postoperative nausea and vomiting intensity scale.
        Br J Anaesth. 2010; 104: 158-166
        • Allen M.L.
        • Leslie K.
        • Jansen N.
        Validation of the postoperative nausea and vomiting intensity score in gynaecological patients.
        Anaesth Intens Care. 2011; 39: 73-78
        • Hakvoort R.A.
        • Elberink R.
        • Vollebregt A.
        • et al.
        How long should urinary bladder catheterisation be continued after vaginal prolapse surgery? A randomised controlled trial comparing short term versus long term catheterisation after vaginal prolapse surgery.
        BJOG. 2004; 111: 828-830